These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25990053)

  • 1. Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.
    Yang ZK; Ying C; Zhao HY; Fang YH; Chen Y; Shen WF
    J Zhejiang Univ Sci B; 2015 May; 16(5):362-9. PubMed ID: 25990053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.
    Linefsky JP; O'Brien KD; Katz R; de Boer IH; Barasch E; Jenny NS; Siscovick DS; Kestenbaum B
    J Am Coll Cardiol; 2011 Jul; 58(3):291-7. PubMed ID: 21737022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.
    Pietrzyk B; Wyskida K; Ficek J; Kolonko A; Ficek R; Więcek A; Olszanecka-Glinianowicz M; Chudek J
    Int Urol Nephrol; 2019 Mar; 51(3):519-526. PubMed ID: 30584645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study.
    Hekimian G; Boutten A; Flamant M; Duval X; Dehoux M; Benessiano J; Huart V; Dupré T; Berjeb N; Tubach F; Iung B; Vahanian A; Messika-Zeitoun D
    Eur Heart J; 2013 Jul; 34(25):1915-22. PubMed ID: 23329150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.
    Nettekoven S; Ströhle A; Trunz B; Wolters M; Hoffmann S; Horn R; Steinert M; Brabant G; Lichtinghagen R; Welkoborsky HJ; Tuxhorn I; Hahn A
    Eur J Pediatr; 2008 Dec; 167(12):1369-77. PubMed ID: 18270736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease.
    Sainger R; Grau JB; Branchetti E; Poggio P; Lai E; Koka E; Vernick WJ; Gorman RC; Bavaria JE; Ferrari G
    J Heart Valve Dis; 2013 Mar; 22(2):156-65. PubMed ID: 23798203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Serum Leptin Level and Calcific Aortic Valve Disease.
    Liu Y; Gu Y; Shen Y; Lin B; Li Y; He X; Zhang Y; Lu L; Shen W; Zhang Q; Yang K
    J Am Heart Assoc; 2019 Oct; 8(19):e012495. PubMed ID: 31566104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
    Kokuho T; Toya Y; Kawaguchi Y; Tamura K; Iwatsubo K; Dobashi Y; Nakazawa A; Takeda H; Iwatsubo M; Hirawa N; Yasuda G; Ohnishi T; Umemura S
    Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone is associated with the LV mass after aortic valve replacement.
    Laflamme MH; Mahjoub H; Mahmut A; Boulanger MC; Larose E; Pibarot P; Mathieu P
    Heart; 2014 Dec; 100(23):1859-64. PubMed ID: 25095827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered bone and mineral metabolism in patients receiving imatinib mesylate.
    Berman E; Nicolaides M; Maki RG; Fleisher M; Chanel S; Scheu K; Wilson BA; Heller G; Sauter NP
    N Engl J Med; 2006 May; 354(19):2006-13. PubMed ID: 16687713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the relation between bone mineral metabolism and mitral annular calcification or aortic valve sclerosis--the relation between mitral annular calcification and postmenopausal osteoporosis in elderly patients].
    Sugihara N; Matsuzaki M; Kato Y
    Nihon Ronen Igakkai Zasshi; 1990 Sep; 27(5):605-15. PubMed ID: 2263019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in biomarkers of mineral and bone metabolism in kidney donors.
    Kasiske BL; Kumar R; Kimmel PL; Pesavento TE; Kalil RS; Kraus ES; Rabb H; Posselt AM; Anderson-Haag TL; Steffes MW; Israni AK; Snyder JJ; Singh RJ; Weir MR
    Kidney Int; 2016 Oct; 90(4):861-8. PubMed ID: 27370408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells.
    Sun JT; Chen YY; Mao JY; Wang YP; Chen YF; Hu X; Yang K; Liu Y
    J Cardiovasc Transl Res; 2019 Dec; 12(6):560-568. PubMed ID: 31367900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women.
    Ling Y; Wang Z; Wu B; Gao X
    J Bone Miner Metab; 2018 May; 36(3):352-363. PubMed ID: 28642975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease.
    Grau JB; Poggio P; Sainger R; Vernick WJ; Seefried WF; Branchetti E; Field BC; Bavaria JE; Acker MA; Ferrari G
    Ann Thorac Surg; 2012 Jan; 93(1):79-86. PubMed ID: 22093695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.
    Park SE; Cho MA; Kim SH; Rhee Y; Kang ES; Ahn CW; Cha BS; Lee EJ; Kim KR; Lee HC; Lim SK
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):854-8. PubMed ID: 17437520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
    Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
    J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease.
    Shuvy M; Abedat S; Eliaz R; Abu-Rmeileh I; Abu-Snieneh A; Ben-Dov IZ; Meir K; Pereg D; Beeri R; Lotan C
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H695-H704. PubMed ID: 31398059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.
    Shuvy M; Abedat S; Beeri R; Danenberg HD; Planer D; Ben-Dov IZ; Meir K; Sosna J; Lotan C
    Cardiovasc Res; 2008 Aug; 79(3):492-9. PubMed ID: 18390899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.